Roquette Completes Acquisition of IFF Pharma Solutions

Roquette, a leader in plant-based ingredients and pharmaceutical excipients, has completed its acquisition of IFF Pharma Solutions. This move enhances Roquette's position in the health industry and supports its ambition to lead the global pharma markets. The acquisition follows Roquette’s purchase of Qualicaps in 2023, further solidifying its foothold.

The integration of IFF Pharma Solutions brings expertise and an innovative product portfolio to Roquette. This transaction allows the company to deliver high-value drug delivery solutions globally, aligning with its strategy to invest in high-growth markets and provide cutting-edge solutions.

CEO Pierre Courduroux expressed enthusiasm about the acquisition, highlighting its alignment with Roquette's strategic vision for innovative excipients that enhance pharmaceutical formulations. Roquette aims to be the go-to partner in the pharmaceutical industry for drug delivery solutions.